COMPARATIVE INCIDENCE OF DE NOVO NONLYMPHOID MALIGNANCIES AFTER LIVER TRANSPLANTATION UNDER TACROLIMUS USING SURVEILLANCE EPIDEMIOLOGIC END RESULT DATA1

Abstract

An increased incidence of de novo cancers in the chronically immunocompromised patient demands careful long-term screening protocols which will help to facilitate the diagnosis at an early stage of the disease. This is particularly true for oropharyngeal cancers where the risk is more than 7 times higher compared to SEER incidence data matched for age, sex, and length of follow-up.